Skip to main content
. 2024 Jul 18;17:95. doi: 10.1186/s12245-024-00676-4

Table 5.

Patients receiving vasopressin, norepinephrine, or both, by age group and detectability of serum epinephrine

Age group Serum epinephrine Total p-value*
Undetectable Detectable OR (95% CI)
n (%) n (%) n (%)
≤ 60 years
Vasopressin, norepinephrine, or both
No 12 (28.6) 5 (11.9) 17 (40.5) 1.00 1.00 (Reference)
Yes 17 (40.5) 8 (19.0) 25 (59.5) 0.88 (0.23; 3.38)
Total 29 (69.1) 13 (30.9) 42 (100.0)
> 60 years
Vasopressin, norepinephrine, or both
No 11 (27.5) 7 (17.5) 18 (45.0) 0.05 1.00 (Reference)
Yes 20 (50.0) 2 (5.0) 22 (55.0) 6.36 (1.12; 36.08)
Total 31 (77.5) 9 (22.5) 40 (100.0)

Patients who were receiving epinephrine (n = 8) were excluded from the analysis

OR odds ratio; 95% CI 95% confidence interval

*Fisher’s exact test